CCIA
NARI

Campbell & Co Investment Adviser’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Campbell & Co Investment Adviser’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21,895
Closed -$1.12M – 1408
2024
Q4 		$1.12M Buy
21,895
+13,069
+148% +$642K 0.09% 348
2024
Q3 		$364K Buy
8,826
+3,998
+83% +$192K 0.03% 831
2024
Q2 		$232K Buy
+4,828
New +$214K 0.02% 917
2024
Q1 		– Sell
-3,308
Closed -$215K – 1418
2023
Q4 		$215K Sell
3,308
-3,855
-54% -$232K 0.02% 1023
2023
Q3 		$468K Sell
7,163
-3,895
-35% -$245K 0.06% 545
2023
Q2 		$643K Buy
+11,058
New +$698K 0.11% 314

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $307M AUM 20.33% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

Campbell & Co Investment Adviser's NARI Position: Q1 2025 in Review

Campbell & Co Investment Adviser sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 21,895 shares — an estimated $1.12M sold.

Campbell & Co Investment Adviser first reported a position in NARI in Q2 2023 and held it in 6 quarters. The position peaked at $1.12M in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Campbell & Co Investment Adviser reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 21,895 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $1.12M.
  • Campbell & Co Investment Adviser first reported a position in Inari Medical, Inc. Common Stock in Q2 2023 and held it in 6 quarters.
  • Campbell & Co Investment Adviser's Inari Medical, Inc. Common Stock position peaked at $1.12M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2025, filed 14 May 2025.